The global herpes zoster therapeutics market is experiencing a period of substantial growth, driven by factors such as an aging population and increasing prevalence of the virus. According to industry analyses, the market is expected to expand at a compounded annual growth rate (CAGR) over the forecast period. Key players in this market are investi